Vanguard Portfolio Management’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$92.3M Sell
9,207,177
-881,313
-9% -$8.15M ﹤0.01% 1513
2026
Q2
$84.4M Buy
10,088,490
+1,219,833
+14% +$11.1M ﹤0.01% 1564
2026
Q1
$79.9M Buy
+8,868,657
New +$140M ﹤0.01% 1514

Other funds holding ADMA

Vanguard Portfolio Management's ADMA Position: Q3 2026 in Review

Vanguard Portfolio Management reduced its ADMA Biologics (ADMA) stake by 8.7% in Q3 2026, selling an estimated $8.15M and leaving 9,207,177 shares worth $92.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1513.

Vanguard Portfolio Management first reported a position in ADMA in Q1 2026 and has held it in 3 quarters since. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Vanguard Portfolio Management held 9,207,177 shares of ADMA Biologics worth $92.3M as of Q3 2026.
  • Vanguard Portfolio Management sold 881,313 ADMA Biologics shares in Q3 2026, an estimated $8.15M.
  • ADMA Biologics made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1513 holding.
  • Vanguard Portfolio Management first reported a position in ADMA Biologics in Q1 2026 and has held it in 3 quarters since.
  • 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.